000			01206nam a2200205Ia 4500
003			MX-MdCICY
005			20250625140643.0
040			_cCICY
090			_aB-11072
245	1	0	_aAntiprotozoal Lysophospholipid Analogues: A Comparison of their Activity Against Trypanosomatid Parasites and Tumor Cells
490	0		_vMini-Reviews in Medicinal Chemistry, 4(2), p.141-151, 2004
520	3		_aLysophospholipid analogues (LPAs), originally developed as anti-cancer agents, have shown significant activity against Leishmania spp. and Trypanosoma cruzi, both in vitro and in vivo. Miltefosine, used as a topical formulation (Miltex.)for metastases, was registered in 2002 for the oral treatment of visceral leishmaniasis. LPAs interfere with lipid synthesis in T. cruzi and cancer cells, but the activity is about >20- fold higher against the parasite.
700	1	2	_aDe Castro, S.L.
700	1	2	_aSanta-Rita, R.M.
700	1	2	_aUrbina, J.A.
700	1	2	_aCroft, S.L.
856	4	0	_uhttps://drive.google.com/file/d/1mEXo5452BfM4Y2Nl9UW0j_6lk4EQPVyD/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c45299 _d45299